Celgene-CELG Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celgene-CELG

CELG 108.24

0.0%

Nov 22 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ben Wa who wrote (539)	6/21/2001 1:53:43 PM
From: Biomaven	Read Replies (2) of 804

The MS take is that this is old news (true). Here's their report: ragingbull.lycos.com Maybe their comment that sales might be a bit light in the short term is more to the point here. It is clear to me that thal will get approval for MM. At that point sales will certainly get a boost, as CELG will be able to properly promote the drug. So any pronounced short-term weakness is probably a buying opportunity for those with a 2-3 year time horizon. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next